stockrowKrystal Biotech, Inc. (KRYS) vs Praxis Precision Medicines, Inc. (PRAX)
- Krystal Biotech, Inc. KRYS 300.31 +0.02%
- Praxis Precision Medicines, Inc. PRAX 276.75 +5.39%
Krystal Biotech, Inc. and Praxis Precision Medicines, Inc. are both Biotechnology companies. Krystal Biotech, Inc. is the larger, with a market value of $8.9B against $7.3B — 1.2× the size. Praxis Precision Medicines, Inc. has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 39.2×. Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against 26.0%. Krystal Biotech, Inc. has the higher net margin (47.9% vs 0.00%) and the higher return on invested capital (27.2% vs −40.6%). Across the 16 metrics below, Krystal Biotech, Inc. leads on 12 and Praxis Precision Medicines, Inc. on 4.
Valuation
Profitability
| Metric | KRYS | PRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.27% | 100.00% | 65.16% |
| Operating margin | 48.41% | 0.00% | 0.00% |
| Net margin | 47.91% | 0.00% | 0.00% |
| Free cash flow margin | 65.97% | 0.00% | 0.00% |
| Return on equity | 17.50% | (38.86%) | (50.12%) |
| Return on assets | 15.93% | (36.80%) | (45.60%) |
| Return on invested capital | 27.15% | (40.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack